Andreas Gravius

1.0k total citations
28 papers, 841 citations indexed

About

Andreas Gravius is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Andreas Gravius has authored 28 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cellular and Molecular Neuroscience, 15 papers in Molecular Biology and 8 papers in Cognitive Neuroscience. Recurrent topics in Andreas Gravius's work include Neuroscience and Neuropharmacology Research (21 papers), Receptor Mechanisms and Signaling (10 papers) and Memory and Neural Mechanisms (7 papers). Andreas Gravius is often cited by papers focused on Neuroscience and Neuropharmacology Research (21 papers), Receptor Mechanisms and Signaling (10 papers) and Memory and Neural Mechanisms (7 papers). Andreas Gravius collaborates with scholars based in Germany, Poland and Russia. Andreas Gravius's co-authors include Wojciech Danysz, M. Pietraszek, Jens Nagel, Caroline Chambon, Nico Wegener, Werner Schmidt, Andrzej Dekundy, Lorenzo Morè, Tanja Weil and Ilya Sukhanov and has published in prestigious journals such as Psychopharmacology, European Journal of Pharmacology and Behavioural Brain Research.

In The Last Decade

Andreas Gravius

26 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Gravius Germany 19 665 418 240 106 83 28 841
Ning Wu China 18 595 0.9× 354 0.8× 199 0.8× 99 0.9× 95 1.1× 43 858
Susan M. Cook United States 17 729 1.1× 576 1.4× 261 1.1× 73 0.7× 70 0.8× 26 1.3k
Zheng‐Ming Ding United States 21 750 1.1× 472 1.1× 208 0.9× 154 1.5× 52 0.6× 44 1.0k
Sami Ben Hamida United States 23 932 1.4× 582 1.4× 269 1.1× 127 1.2× 166 2.0× 43 1.3k
Lucia Ciranna Italy 18 659 1.0× 518 1.2× 327 1.4× 86 0.8× 73 0.9× 44 1.2k
Stephen N. Mitchell United Kingdom 17 527 0.8× 313 0.7× 234 1.0× 56 0.5× 130 1.6× 26 774
Thomas M. Sanderson United Kingdom 14 565 0.8× 372 0.9× 262 1.1× 98 0.9× 65 0.8× 20 821
Matthew A. Seager United States 21 696 1.0× 429 1.0× 377 1.6× 141 1.3× 130 1.6× 32 1.1k
Feng Yi United States 15 844 1.3× 611 1.5× 193 0.8× 119 1.1× 87 1.0× 32 1.2k
Naheed Mirza Denmark 19 486 0.7× 508 1.2× 166 0.7× 185 1.7× 80 1.0× 24 857

Countries citing papers authored by Andreas Gravius

Since Specialization
Citations

This map shows the geographic impact of Andreas Gravius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Gravius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Gravius more than expected).

Fields of papers citing papers by Andreas Gravius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Gravius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Gravius. The network helps show where Andreas Gravius may publish in the future.

Co-authorship network of co-authors of Andreas Gravius

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Gravius. A scholar is included among the top collaborators of Andreas Gravius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Gravius. Andreas Gravius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Danysz, Wojciech, Niels Hansen, Jens Wiltfang, et al.. (2025). Memantine: updates from the past decade and implications for future novel therapeutic applications. Journal of Neural Transmission.
2.
3.
Westmark, Pamela R., Andrzej Dekundy, Andreas Gravius, Wojciech Danysz, & Cara J. Westmark. (2018). Rescue of Fmr1 phenotypes with mGluR5 inhibitors: MRZ-8456 versus AFQ-056. Neurobiology of Disease. 119. 190–198. 19 indexed citations
4.
Gravius, Andreas, et al.. (2017). Further pharmacological characterization of eltoprazine: focus on its anxiolytic, anorexic, and adverse‑effect potential. Acta Neurobiologiae Experimentalis. 77(1). 77–85. 2 indexed citations
5.
Rammes, Gerhard, Andreas Gravius, Maarten Ruitenberg, et al.. (2015). MRZ-99030 – A novel modulator of Aβ aggregation: II – Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice. Neuropharmacology. 92. 170–182. 22 indexed citations
6.
Hohenstein-Blaul, Nadine von Thun und, Oliver W. Gramlich, Maarten Ruitenberg, Andreas Gravius, & Franz H. Grus. (2013). β-Amyloid deposition in human glaucomatous retinae revealed by proteomic and immunohistochemical analyses. Investigative Ophthalmology & Visual Science. 54(15). 1139–1139. 1 indexed citations
7.
Hofmann, M., Andreas Gravius, Kata Bölcskei, et al.. (2012). Assessment of the effects of NS11394 and L-838417, α2/3 subunit-selective GABAA receptor-positive allosteric modulators, in tests for pain, anxiety, memory and motor function. Behavioural Pharmacology. 23(8). 790–801. 14 indexed citations
8.
Chambon, Caroline, Claudia Jatzke, Nico Wegener, Andreas Gravius, & Wojciech Danysz. (2012). Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication. European Journal of Pharmacology. 697(1-3). 73–80. 24 indexed citations
9.
Wegener, Nico, Jens Nagel, Caroline Chambon, et al.. (2011). Evaluation of brain pharmacokinetics of (+)MK-801 in relation to behaviour. Neuroscience Letters. 503(1). 68–72. 46 indexed citations
10.
Chambon, Caroline, Nico Wegener, Andreas Gravius, & Wojciech Danysz. (2011). A new automated method to assess the rat recognition memory: Validation of the method. Behavioural Brain Research. 222(1). 151–157. 32 indexed citations
11.
Dekundy, Andrzej, Andreas Gravius, Mirko Hechenberger, et al.. (2010). Pharmacological characterization of MRZ-8676, a novel negative allosteric modulator of subtype 5 metabotropic glutamate receptors (mGluR5): focus on l-DOPA-induced dyskinesia. Journal of Neural Transmission. 118(12). 1703–1716. 22 indexed citations
12.
Gravius, Andreas, M. Pietraszek, Andrzej Dekundy, & Wojciech Danysz. (2010). Metabotropic Glutamate Receptors as Therapeutic Targets for Cognitive Disorders. Current Topics in Medicinal Chemistry. 10(2). 187–206. 34 indexed citations
13.
Jacob, W., Andreas Gravius, M. Pietraszek, et al.. (2009). The anxiolytic and analgesic properties of fenobam, a potent mGlu5 receptor antagonist, in relation to the impairment of learning. Neuropharmacology. 57(2). 97–108. 52 indexed citations
14.
Pietraszek, M., et al.. (2009). Effects of a positive allosteric modulator of mGluR5 ADX47273 on conditioned avoidance response and PCP-induced hyperlocomotion in the rat as models for schizophrenia. Pharmacology Biochemistry and Behavior. 95(1). 23–30. 45 indexed citations
15.
Pietraszek, M., et al.. (2009). Comparison of the mGlu5 receptor positive allosteric modulator ADX47273 and the mGlu2/3 receptor agonist LY354740 in tests for antipsychotic-like activity. European Journal of Pharmacology. 623(1-3). 73–83. 39 indexed citations
16.
Morè, Lorenzo, Andreas Gravius, M. Pietraszek, et al.. (2007). Comparison of the mGluR1 antagonist A-841720 in rat models of pain and cognition. Behavioural Pharmacology. 18(4). 273–281. 16 indexed citations
17.
18.
Gravius, Andreas, M. Pietraszek, Werner Schmidt, & Wojciech Danysz. (2006). Functional interaction of NMDA and group I metabotropic glutamate receptors in negatively reinforced learning in rats. Psychopharmacology. 185(1). 58–65. 17 indexed citations
19.
Pietraszek, M., et al.. (2005). mGluR5, but not mGluR1, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition. Neuropharmacology. 49(1). 73–85. 74 indexed citations
20.
Gravius, Andreas, et al.. (2005). Effects of mGlu1 and mGlu5 receptor antagonists on negatively reinforced learning. Behavioural Pharmacology. 16(2). 113–121. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ning Wu Breakdown of academic impact, for papers by Susan M. Cook Breakdown of academic impact, for papers by Zheng‐Ming Ding Breakdown of academic impact, for papers by Sami Ben Hamida Breakdown of academic impact, for papers by Lucia Ciranna Breakdown of academic impact, for papers by Stephen N. Mitchell Breakdown of academic impact, for papers by Thomas M. Sanderson Breakdown of academic impact, for papers by Matthew A. Seager Breakdown of academic impact, for papers by Feng Yi Breakdown of academic impact, for papers by Naheed Mirza
Rankless by CCL
2026